10-Q: Plexus Corp. Reports First Quarter Fiscal 2025 Results, Net Income Rises 27.7%
Quarterly Report
Plexus Corp. saw a 27.7% increase in net income for the first quarter of fiscal year 2025, despite a slight decrease in net sales.
Summary
- Plexus Corp.'s net sales for the first quarter of fiscal year 2025 decreased slightly by 0.7% to $976.1 million compared to $982.6 million in the same period last year.
- The company's gross profit increased by 14.3% to $100.7 million, with a gross margin of 10.3%, up from 9.0% last year.
- Operating income rose by 3.8% to $46.9 million, and the operating margin increased to 4.8% from 4.6%.
- Net income for the quarter was $37.3 million, a 27.7% increase from $29.2 million in the prior year.
- Diluted earnings per share increased to $1.34, up from $1.04 in the same quarter of the previous year.
- The company's return on invested capital (ROIC) was 13.8%, with an economic return of 4.9%.
- Cash and cash equivalents and restricted cash totaled $317.8 million as of December 28, 2024.
- The company repurchased 84,823 shares for $12.8 million during the quarter, with $37.2 million remaining under the current share repurchase program.
- The company expects capital expenditures for fiscal year 2025 to be between $120 million and $150 million.
Sentiment
Score: 8
Explanation: The document shows strong positive results in net income, gross profit, and operating income, with a clear focus on improving financial performance. While there are some negative aspects like a slight decrease in net sales and increased expenses, the overall tone is positive and indicates a healthy financial position and effective management.
Positives
- The company experienced a significant increase in net income, demonstrating improved profitability.
- Gross profit and gross margin improved, indicating better cost management and pricing strategies.
- Operating income and operating margin also saw increases, reflecting enhanced operational efficiency.
- Diluted earnings per share increased, benefiting shareholders.
- The company's ROIC and economic return improved, showing effective capital management.
- Plexus successfully reduced its cash cycle days, indicating better working capital management.
- The company has $37.2 million remaining under its share repurchase program, which could further benefit shareholders.
Negatives
- Net sales decreased slightly by 0.7% compared to the same quarter last year.
- The AMER segment experienced a decrease in net sales of 11.6%.
- The EMEA segment also saw a decrease in net sales of 16.6%.
- Selling and administrative expenses increased by $6.2 million.
- Restructuring and other charges totaled $4.7 million for the quarter.
Risks
- The company faces risks related to inflationary pressures on production costs.
- Shortages and delays in obtaining components could impact production.
- Customer delays, changes, cancellations, or forecast inaccuracies could affect revenue.
- The company is exposed to risks associated with excess and obsolete inventory.
- Fluctuations in currency exchange rates could impact financial results.
- The company is subject to increasing regulatory and compliance requirements.
- The company is currently under examination by taxing authorities in the U.S. and a foreign jurisdiction.
- The company may need to arrange additional debt or equity financing if future financing needs increase.
Future Outlook
The company believes that its projected cash flows, available cash, potential borrowings, and leasing capabilities should be sufficient to meet its working capital and fixed capital requirements for the next twelve months. The company estimates capital expenditures for fiscal 2025 will be approximately $120.0 million to $150.0 million.
Management Comments
- Management measures operational performance and allocates resources on a geographic segment basis.
- The company's global business development strategy is based on targeted market sectors.
- Management uses a financial model that is aligned with the business strategy and includes an ROIC goal of 15%.
Industry Context
The company operates in the electronics manufacturing services (EMS) industry, serving the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The results reflect the current market conditions and customer demand within these sectors. The company's focus on value-add sales and operational efficiency is consistent with industry trends.
Comparison to Industry Standards
- Plexus's gross margin of 10.3% is within the typical range for EMS providers, but the increase of 130 basis points year-over-year indicates strong performance.
- The company's ROIC of 13.8% is a positive sign, as it exceeds the company's weighted average cost of capital (WACC) of 8.9%, indicating efficient use of capital.
- Compared to competitors like Jabil and Flex, Plexus's focus on high-complexity products and regulated industries may result in different margin profiles.
- The decrease in cash cycle days to 68 days is a positive indicator of improved working capital management, which is a key metric for EMS companies.
- The company's share repurchase program is a common practice among publicly traded companies to return value to shareholders.
Legal Proceedings
- The Company is party to lawsuits in the ordinary course of business, but management does not believe that any such proceedings will have a material effect on the company's financial position.
Stakeholder Impact
- Shareholders will benefit from increased net income and earnings per share.
- Employees may be impacted by restructuring activities, including workforce reductions.
- Customers may benefit from the company's focus on delivering high-quality products and services.
- Suppliers may be impacted by changes in the company's procurement and payment practices.
- Creditors may be impacted by the company's debt management and financing activities.
Next Steps
- The company will continue to execute its share repurchase program.
- The company will continue to monitor and manage its supply chain.
- The company will continue to focus on value-add sales in each region.
- The company will continue to invest in capital expenditures to support new program ramps and replace older equipment.
Key Dates
| Date | Description |
|---|---|
| August 18, 2022 | The Board of Directors approved a share repurchase program (the '2023 Program'). |
| January 16, 2024 | The company announced a share repurchase program (the '2024 Program'). |
| August 14, 2024 | The Board of Directors approved a share repurchase program (the '2025 Program'). |
| December 28, 2024 | End of the fiscal quarter. |
| January 28, 2025 | There were 27,040,158 shares of common stock outstanding. |
| January 31, 2025 | Date of the report. |
Keywords
electronics manufacturing, contract manufacturing, net income, gross profit, operating income, ROIC, share repurchase, cash flow, supply chain, financial results
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.